Correction: BrainCool AB (publ) - Financial Report for Q1 2024
Börskollen - Aktier, fonder och ekonominyheter

Börskollen

För dig med koll på börsen

•Nyhetsbrev: Stockpickerns våta dröm: Fem aktier med ”tiotaggar-potential” / Efter kursraset: Tre färska köpråd för fastighetsbolaget

Pressmeddelande

Correction: BrainCool AB (publ) - Financial Report for Q1 2024

MFN Publicerad: 15 Apr 2024 19:03
BrainCool

There is an error in Business Segment page 5. It is stated that the deliveries of the 350 Systems to ZOLL® will be carried out over 12-18 months. The correct fact is a period over 24 months.

Contact
For more information
Jon Berg - CEO
+46 722 50 91 19
E-mail: [email protected]

About Us
BrainCool AB (publ) is an innovative medical device company that develops, markets, and sells leading medical cooling systems for indications and areas with significant medical benefits within the healthcare sector. BrainCool AB (publ) is based in Lund, Sweden, and its share is listed on Nasdaq First North Growth Market, named “BRAIN”.
Eminova Fondkommission AB is the company’s Certified Adviser.

This information is information that BrainCool is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-04-15 19:03 CEST.

Attachments
Q1 2024 Report Corrected

Bifogade filer

Q1 2024 Report Correctedhttps://storage.mfn.se/73d9d1aa-b8dd-4bd0-bcda-c2094eab47ea/q1-2024-report-corrected.pdf

Nyheter om BrainCool

Läses av andra just nu

Om aktien BrainCool

Senaste nytt